Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy
EM-MAT
Multicentre Randomised Controlled Trial of Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy(EM-MAT Trial)
1 other identifier
interventional
200
1 country
1
Brief Summary
This is a multi-centre, randomised, double-blind, placebo-controlled trial with two parallel groups in a 1:1 allocation to study the efficacy of Pulsed Electromagnetic Field Therapy (PEMF) in patients with mid-portion Achilles tendinopathy. All participants will be randomly divided into two groups: an intervention group (active PEMF and standard rehabilitation exercise) and a control group (sham PEMF and standard rehabilitation exercise). All self-reported, functional, and ultrasound findings will be evaluated by the investigator at baseline assessment, 1-month, 2-month, 3-month, 6-month and 12-month follow-up after initiating the intervention. The researcher will obtain written consent from all participants before the start of this study. All eligible participants will be informed about this study and given enough time to consider whether or not to participate; the clinician/research staff will answer all questions asked by the participants. The trial will be conducted in accordance with the Declaration of Helsinki and the ICH-GCP. Clinical research ethics approval for the trial will be obtained from the Joint Clinical Research Ethics Committee of The Chinese University of Hong Kong. All participants will be recruited from the clinics and centres of the participating institutions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2025
CompletedStudy Start
First participant enrolled
October 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
March 25, 2026
March 1, 2026
8 months
April 24, 2025
March 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Victorian Institute of Sports Assessment (VISA-A)
The primary outcome measure will be the Victorian Institute of Sport Assessment (VISA-A) questionnaire, available in either the original English or validated Chinese version, depending on the participant's native language. This specific scoring system developed for the Achilles tendon is the most widely used score for clinical Achilles research. The VISA-A is scored on a scale of 0 to 100; lower scores indicate more severity of symptoms, while a score of 100 indicates a healthy and pain-free Achilles tendon.
Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention
Secondary Outcomes (8)
Numeric Pain Rating Scale (NPRS)
Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention
Foot and Ankle Outcome Scores (FAOS)
Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention
Achilles tendon resting angle (ATRA)
Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention
Tendon thickness
Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention
Tendon cross sectional area
Baseline;2-month;3-month;6-month;12month follow-up after initiating the intervention
- +3 more secondary outcomes
Study Arms (2)
PEMF Therapy + Exercise
EXPERIMENTALsham Therapy + Exercise
SHAM COMPARATORInterventions
The PEMF will be delivered using a BIXEPS device (Quantum Tx, Singapore) ; It is utilised by the patient placing the leg into the machine. This device is operated by participant individualized NFC cards, which will be centrally programmed to deliver either active PEMF (uniform 1mT, 50Hz) or sham PEMF (0mT, 0Hz) for 30 minutes. Because this biophysical intervention is non-invasive, and the electromagnetic fields emitted into the legs do not generate any sensation (e.g. heat, sound), participants will be blinded to the treatment. The protocol will be 180 minutes of PEMF therapy, performed in six 30-minute sessions 3 times a week and completed in 2 weeks.
All participants will be subject to a standardised rehabilitation exercise region consisting of stretching and eccentric exercises following the Alfredson protocol. The 12-week program will be taught by a physiotherapist or athletic trainer and supplemented by video tutorials. The regime begins with three 30-second static stretches for the gastrocnemius (knee extension) and soleus (knee flexion) muscles with 1-minute rest between each stretch. The 2nd part is eccentric exercises to the calves following the Alfredson protocol. This will be three sets of eccentric exercises lasting 12 weeks, with 15 sets twice a day. If participants are unable to complete three sets of 15 repetitions, they can start with fewer repetitions and sets (at least 2 sets of 10 repetitions each) and gradually increase to the total number of sets. Participants will perform the static stretching exercises from Step 1 at the end of each session
Eligibility Criteria
You may qualify if:
- Adults (\>18 years of age)
- Clinical diagnosis of mid-Achilles tendinopathy
- VISA-A score of \<60
- Ultrasound evidence of Achilles tendinopathy (thickening \>7mm)
You may not qualify if:
- Previous invasive treatment to the Achilles tendon (e.g. rupture repair, PRP injection etc)
- Contraindication to PEMF (e.g. pregnancy, pacemakers)
- Physical or psychological comorbidities impairing the ability to complete assessments (eg neurological deficits etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Shatin, New Territories, 000000, Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor of Orthopaedics and Traumatology, CUHK Head of the Foot and Ankle Team / Honorary Associate Consultant, Prince of Wales Hospital Specialist in Orthopaedics and Traumatology, CUHK Medical Centre
Study Record Dates
First Submitted
April 24, 2025
First Posted
May 14, 2025
Study Start
October 15, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
March 25, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- From 2028-5-31 to 2033-5-28
only IPD used in the results publication